Figure 3From: Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate Serum levels of IL-6 (pg/ml) during the EPI treatment and FU in the telmisartan and placebo arms. Back to article page